PROQR THERAPEUTICS NV (PRQR)
NL0010872495 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 89.40M | 118.92M | 94.80M | 187.50M | 75.80M | |||
| Cash Equivalents | N/A | N/A | N/A | 187.52M | 0.00 | |||
| Marketable Securities | 0.00 | N/A | N/A | N/A | N/A | |||
| Receivables | 770.00K | 745.00K | 56.60M | 300.00K | 400.00K | |||
| Other Current Assets | 2.24M | 1.32M | 3.00M | 3.70M | 3.80M | |||
| Total Current Assets | 92.41M | 120.99M | 154.50M | 191.50M | 80.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 14.44M | 16.90M | 16.20M | 17.50M | 18.60M | |||
| Investments And Advances | 0.00 | 0.00 | 600.00K | 600.00K | 100.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 14.44M | 16.90M | 16.80M | 18.10M | 18.70M | |||
| TOTAL ASSETS | 106.85M | 137.88M | 171.30M | 209.60M | 98.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 5.90M | 1.61M | 3.90M | 6.30M | 2.40M | |||
| Accrued Expenses | 1.37M | 1.66M | 1.10M | 1.20M | 0.00 | |||
| Accounts Payable | 31.00K | 1.54M | 400.00K | 200.00K | 200.00K | |||
| Other Current Liabilities | 32.34M | 29.39M | 15.70M | 19.90M | 7.70M | |||
| Total Current Liabilities | 39.64M | 34.20M | 21.10M | 27.60M | 10.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 11.50M | 18.12M | 18.10M | 54.10M | 31.90M | |||
| Other Non-Current Liabilities | 30.73M | 44.17M | 67.00M | 14.70M | N/A | |||
| Total Non-Current Liabilities | 42.23M | 62.29M | 84.70M | 68.10M | 31.30M | |||
| TOTAL LIABILITIES | 81.87M | 96.49M | 105.80M | 95.70M | 41.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -418.02M | -400.85M | -380.70M | -317.80M | -257.70M | |||
| Additional Paid In Capital | 416.44M | 416.26M | 415.90M | 401.30M | 290.90M | |||
| Minority Interest | N/A | 0.00 | -400.00K | -600.00K | -500.00K | |||
| Other Shareholders' Equity | 26.57M | 25.98M | 30.30M | 30.30M | 23.90M | |||
| Shares Outstanding | 84.25M | 84.25M | 84.20M | 74.90M | 54.10M | |||
| Tangible Book Value per Share | 0.30 | 0.49 | 0.78 | 1.52 | 1.06 | |||
| Total Shareholders' Equity | 24.98M | 41.39M | 65.50M | 113.80M | 57.10M | |||
| TOTAL LIABILITIES AND EQUITY | 106.85M | 137.88M | 171.30M | 209.60M | 98.70M | |||
| Statistics | ||||||||
| Debt/Equity | 0.46 | 0.44 | 0.28 | 0.48 | 0.56 | |||
| Current Ratio | 2.33 | 3.54 | 7.32 | 6.94 | 7.77 | |||
| Return On Assets (ROA) | -22.41% | -20.39% | -38.01% | -29.40% | -47.18% | |||
| Return On Equity (ROE) | -95.83% | -67.94% | -99.40% | -54.15% | -81.56% | |||
All data in EUR , ROIC based on taxRate of 0.21